Suchergebnisse - "Fowler, Nathan H"

PubPharm (109)

1

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma : An open label, phase 2 study

enthalten in: Cancer | 2024

von Gordon, M. | Feng, L. | Strati, P. | +20

2

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma : An open label, phase 2 study

enthalten in: Cancer | 2024

von Gordon, M. | Feng, L. | Strati, P. | +20

3

Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells

enthalten in: Cell reports. Medicine | 2023

von Strati, P. | Li, X. | Deng, Q. | +25

4

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

enthalten in: Blood advances | 2022

von Salles, G. | Schuster, S. | Dreyling, M. | +17

5

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

enthalten in: bioRxiv.org | 2022

von Ma, M. | Tadros, S. | Bouska, A. | +33

6

Six-Year Results From RELEVANCE : Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Morschhauser, F. | Nastoupil, L. | Feugier, P. | +34

7

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

enthalten in: Blood cancer discovery | 2022

von Han, G. | Deng, Q. | Marques-Piubelli, M. | +31

CommentIn: Blood Cancer Discov. 2022 Sep 6;3(5):374-377. - PMID 35917283

8

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

enthalten in: Blood | 2022

von Cherng, H. | Sun, R. | Sugg, B. | +22

CommentIn: Blood. 2022 Aug 4;140(5):414-415. - PMID 35925642

9

SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

enthalten in: Blood advances | 2022

von Marques-Piubelli, M. | Parra, E. | Feng, L. | +17

10

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

enthalten in: Haematologica | 2022

von Ma, M. | Tadros, S. | Bouska, A. | +33

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]